2024
Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention
Pettersen T, Schjøtt J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekvål T, Investigators C. Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention. Heart Lung And Circulation 2024, 33: 350-361. PMID: 38238118, DOI: 10.1016/j.hlc.2023.12.005.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPrescribed pharmacotherapyPotential adverse drug reactionsAdverse drug reactionsPercutaneous coronary interventionPatient-reported outcome measuresCovariate-adjusted logistic regressionConfidence intervalsNational quality registryProspective multicentre cohort studyAssociated with incidencePatients' medical recordsIntervention aimHealthcare providersQuality registryMulticentre cohort studyDischarge informationDrug reactionsInformation patientsOdds ratioOutcome measuresCohort studyHospital dischargeLogistic regressionPCI centre
2023
Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention
Pettersen T, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval T. Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. European Heart Journal 2023, 44: ehad655.2879. DOI: 10.1093/eurheartj/ehad655.2879.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPercutaneous coronary interventionAdverse drug reactionsPotential adverse drug reactionsPrescribed therapyCoronary interventionHospital dischargeDrug reactionsMedical recordsOdds ratioIncidence of ADRsProspective multicentre cohort studyMore adverse drug reactionsMulticentre cohort studyAcute coronary syndromeSex differencesTotal study populationConfidence intervalsPatients' medical recordsClinical drug trialsProportion of womenHeart ContinuityCoronary syndromeCohort studyPCI center
2022
Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions
Pettersen T, Schjott J, Allore H, Bendz B, Borregaard B, Fridlund B, Hadjistavropoulos H, Larsen A, Nordrehaug J, Rasmussen T, Rotevatn S, Valaker I, Wentzel-Larsen T, Norekval T. Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions. European Heart Journal 2022, 43: ehac544.2736. DOI: 10.1093/eurheartj/ehac544.2736.Peer-Reviewed Original ResearchSelf-reported adverse drug reactionsPercutaneous coronary interventionAdverse drug reactionsPotential adverse drug reactionsHospital dischargePrescribed therapyDrug reactionsCoronary interventionMedical recordsOdds ratioIncidence of ADRsProspective multicentre cohort studyStable coronary artery diseaseMulticentre cohort studyCoronary artery diseaseConfidence intervalsPatients' medical recordsHeart ContinuityInforming PatientsMore comorbiditiesIndex hospitalizationCohort studyArtery diseasePCI centerClinical variables